Astrana Health (ASTH) director Weili Dai receives 4,525-share restricted stock grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Dai, Weili reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health director Weili Dai received a grant of 4,525 shares of restricted common stock under the company’s 2024 Equity Incentive Plan. These shares vest on the earlier of June 10, 2027 or the date of Astrana Health’s 2027 annual stockholders meeting, bringing Dai’s direct holdings to 18,188 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Dai, Weili
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,525 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 18,188 shares (Direct, null)
Footnotes (1)
- Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Key Figures
Restricted stock grant: 4,525 shares
Price per share for grant: $0.00 per share
Total shares after transaction: 18,188 shares
+1 more
4 metrics
Restricted stock grant
4,525 shares
Common stock award to director Weili Dai
Price per share for grant
$0.00 per share
Equity compensation, not open-market purchase
Total shares after transaction
18,188 shares
Dai’s direct holdings following the award
Vesting date trigger
June 10, 2027
Earlier of this date or 2027 annual meeting
Key Terms
restricted stock, 2024 Equity Incentive Plan, vest
3 terms
restricted stock financial
"Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027..."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
2024 Equity Incentive Plan financial
"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan..."
vest financial
"which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did Astrana Health (ASTH) director Weili Dai report on this Form 4?
Director Weili Dai reported receiving a grant of 4,525 shares of restricted Astrana Health common stock. The award was issued at no cash cost as part of equity compensation and increases Dai’s direct holdings to 18,188 shares after the transaction.
Under which plan was Weili Dai’s Astrana Health (ASTH) equity award granted?
The 4,525 restricted shares were granted under Astrana Health’s 2024 Equity Incentive Plan. This plan provides stock-based compensation to directors and other eligible participants, aligning part of their compensation with the company’s common stock performance over time.